Bjophthalmol-2020-318090 1..2

Total Page:16

File Type:pdf, Size:1020Kb

Bjophthalmol-2020-318090 1..2 At a glance Br J Ophthalmol: first published as 10.1136/bjophthalmol-2020-318090 on 26 October 2020. Downloaded from Highlights from this issue doi:10.1136/bjophthalmol-2020-318090 Keith Barton , James Chodosh , Jost B Jonas , Editors in chief Glaucoma in the Northern Ireland Cohort The effect of partial posterior vitreous Comparison of OCT angiography in for the Longitudinal Study of Ageing detachment on spectral-domain optical children with a history of intravitreal (NICOLA): cohort profile, prevalence, coherence tomography retinal nerve fibre injection of ranibizumab vs laser awareness and associations (seepage1492) layer thickness measurements photocoagulation for retinopathy of The crude prevalence of glaucoma in (seepage1524) prematurity (see page 1556) Northern Ireland of 2.83% (95% CI Among glaucoma suspects, eyes with par- In this cross-sectional study, we found that 2.31%, 3.46%) is comparable to other tial posterior vitreous detachments, com- the central foveal vessel length density and European population-based studies. pared to eyes without, were associated perfusion density, the foveal avascular Approximately two thirds of people with with greater average, superior, and inferior zone area and central foveal thicknesses glaucoma were undiagnosed. Associations retinal nerve fibre layer thickness of children who had undergone different with glaucoma were consistent with cur- measurements. treatments, might vary. rent understanding of the disease. Three-year follow-up of choroidal Comparison of central visual sensitivity Selective laser trabeculoplasty vs neovascularisation in eyes of chronic between monocular and binocular testing medication for open-angle glaucoma: central serous chorioretinopathy in advanced glaucoma patients using imo systematic review and meta-analysis of (see page 1561) perimetry (see page 1528) randomised clinical trials (see page 1500) After an average of 3 years of follow, most In glaucomatous eyes, better-eye central Selective laser trabeculoplasty is a safe and patients remained clinically stable without sensitivity was better and worse-eye cen- effective IOP-lowering therapy for open- the persistence of subretinal fluid despite tral sensitivity was poorer, under binocular angle glaucoma. The patients received significant structural changes in choroidal than monocular conditions. Monocular selective laser trabeculoplasty need signifi- neovascularisation on optical coherence visual-field measurements should be care- cant lower number of medications. tomography angiography. fully considered when assessing advanced Anterior chamber particles are associated glaucoma patients. Comparison of various surgical with reduction of intraocular pressure techniques for optic disc pit after selective laser trabeculoplasty (see The effect of low dose atropine on myopia maculopathy: vitrectomy with internal page 1508) progression, pupil diameter and limiting membrane (ILM) peeling alone The number of the anterior chamber par- accommodative amplitude—low dose vs inverted ILM flap ‘plug’ vs ticles evaluated with anterior segment atropine and myopia progression autologous scleral ‘plug’ (see page 1567) optical coherence tomography immedi- (see page 1535) Resolution of maculopathy in cases of ately after selective laser trabeculoplasty In a one-year study, the myopia progres- optic disc pits is swifter if the pit is plugged http://bjo.bmj.com/ correlates significantly with intraocular sion effects of low dose atropine were dose using either an inverted internal limiting pressure reduction at least for 3 months dependent however the side effect profile membrane flap or scleral flap, compared after the procedure. was independent of dosage. to vitrectomy alone. Efficacy and safety evaluation of ORCA study: Real-world vs reading centre benzalkonium chloride preserved Objectively measured near work, outdoor assessment of disease activity of eye-drops compared with alternatively exposure and myopia in children neovascular age-related macular on September 25, 2021 by guest. Protected copyright. preserved and preservative-free eye-drops (see page 1542) degeneration (nAMD) (see page 1573) in the treatment of glaucoma: a systematic According to the objective data, the time Lack of treatment despite correct identifi- review and meta-analysis (see page 1512) spent with a light intensity of >3000 lux cation of CNV activity was detected in the This systematic review, based on 16 rando- was a protective factor against myopia, ORCA study. Not only can misinterpreta- mised clinical trials, could not determine while the time spent with a working distance tion of SD-OCT lead to vision loss over significant differences in efficacy or safety of <20 cm was a risk factor for myopia. between benzalkonium chloride-preserved time, but also lack of treatment despite prostaglandin analogue and beta-blocker correct interpretation. eye drops compared to alternatively pre- Long-term (20-year) real-world outcomes served or preservative-free eye drops. of intravenous chemotherapy Comparison of true-colour wide-field (chemoreduction) for retinoblastoma in confocal scanner imaging with standard First-in-human continuous 24-h 964 eyes of 554 patients at a single centre fundus photography for diabetic measurement of intraocular pressure and (see page 1548) retinopathy screening (see page 1579) ocular pulsation using a novel contact lens A 20-year analysis of 964 eyes with retino- Vision-threatening diabetic retinopathy sensor (see page 1519) blastoma treated with intravenous che- features which are missed with standard A first-in-man study is reported using con- motherapy revealed tumour control fundus cameras, can be detected with the tact lens that measures intraocular pressure (avoidance of enucleation and external true-colour, wide-field EIDON confocal and ocular pulsation in mm Hg. This novel beam radiotherapy) for Groups A, B, and scanner. Clinically relevant differences in device is also able to detect physiological Cat≥91%, D at 71%, and E at 32% grading result in more referrals for sight- and induced intraocular pressure variations. (p<0.001). threatening disease when using the EIDON. Br J Ophthalmol November 2020 Vol 104 No 11 i At a glance Br J Ophthalmol: first published as 10.1136/bjophthalmol-2020-318090 on 26 October 2020. Downloaded from Effectiveness of an innovative and Visual and refractive outcomes and Microsporidial stromal keratitis: comprehensive eye care model for complications in femtosecond laser-assisted characterisation of clinical features, individuals in residential care facilities: vs conventional phacoemulsification cataract ultrastructural study by electron surgery: findings from a randomised, results of the residential ocular care microscopy, and efficacy of different surgical (ROC) multicentred randomised controlled clinical trial (see page 1596) Post-operative refractive and visual out- modalities (see page 1613) controlled trial (see page 1585) The current study highlights that medi- In this randomised controlled trial, we comeswerecomparablebetweenfemtose- cond laser-assisted cataract surgery and cal therapy is ineffective for microspor- showed that an integrated eye assessment conventional phacoemulsification surgery. idal stromal keratitis and surgical and intervention programme improved Complication rates were low in both groups. intervention is a requisite to prevent near vision, emotional well-being and per- the extensive spread of mature spores ceived vision quality in the short-term for Long-term visual outcomes of the boston type i keratoprosthesis in canada in the corneal stroma; however, surgical visually impaired residential care dwellers (see page 1601) therapy was associated with overall poor in Australia. A retrospective cohort study of consecutive outcome. Boston type I keratoprosthesis procedures Observation of nine previously reported showed 61.8% of eyes maintained better and ten unreported SLC4A11 mutations Normative patterns and factors associated than preoperative visual acuity 7 years post- among 20 Iranian CHED probands and with presbyopia progression in operatively; the main risk factor for irrever- sible vision loss was preoperative glaucoma. identification of an MPDS mutation as a multiethnic Asian population: the possible cause of CHED and FECD in one Singapore Epidemiology of Eye Diseases Three-year follow-up of accelerated transepithelial corneal cross-linking for family (see page 1621) Study (see page 1591) Screening of SLC4A11 in CHED patients We found that the overall near addition progressive paediatric keratoconus (see page 1608) and exome sequencing revealed unre- power in Asians was lower than current Keratometry and corneal thickness remained ported mutations and identification of recommended guidelines. Additionally, stable after accelerated transepithelial cor- MPDZ which, similarly to SLC4A11, Malays demonstrated the highest rate of neal cross-linking (ATE-CXL) for the pae- affects membrane transport and is presbyopia progression in comparison to diatric progressive keratoconus patients a possible cause of CHED and FECD in Chinese and Indians. during the 36-month follow-up period. one family. http://bjo.bmj.com/ on September 25, 2021 by guest. Protected copyright. ii Br J Ophthalmol November 2020 Vol 104 No 11.
Recommended publications
  • Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
    Glaucoma Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma Jessica Tang,1,2 Flora Hui,1 Xavier Hadoux,1 Bernardo Soares,3 Michael Jamieson,3 Peter van Wijngaarden,1–3 Michael Coote,1–3 and Jonathan G. Crowston1,2,4,5 1Glaucoma Research Unit, Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia 2Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Australia 3Royal Victorian Eye and Ear Hospital, Melbourne, Australia 4Centre for Vision Research, Duke-NUS Medical School, Singapore, Singapore 5Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore Correspondence: Jessica Tang, PURPOSE. To evaluate the short-term changes in inner retinal function using the photopic Glaucoma Research Unit, Centre for negative response (PhNR) after intraocular pressure (IOP) reduction in glaucoma. Eye Research Australia, Royal Victorian Eye and Ear Hospital, METHODS. Forty-seven participants with glaucoma who were commencing a new or addi- Level 7, Peter Howson Wing, 32 tional IOP-lowering therapy (treatment group) and 39 participants with stable glau- Gisborne St, East Melbourne, VIC coma (control group) were recruited. IOP, visual field, retinal nerve fiber layer thick- 3002, Australia; ness, and electroretinograms (ERGs) were recorded at baseline and at a follow-up visit [email protected]. (3 ± 2 months). An optimized protocol developed for a portable ERG device was used Received: August 29, 2019 to record the PhNR. The PhNR saturated amplitude (Vmax), Vmax ratio, semi-saturation Accepted: June 16, 2020 constant (K), and slope of the Naka–Rushton function were analyzed. Published: August 7, 2020 RESULTS.
    [Show full text]
  • Laser Learning Lecture and Lab: YAG Caps, LPI, And
    5/9/17 Overview Laser Learning Lecture and Lab: • Why we use lasers YAG caps, LPI, and SLT • YAG capsulotomy • Laser Peripheral Iridotomy (LPI or PI) Aaron McNulty, O.D., F.A.A.O. • Argon Laser Peripheral Iridoplasty (ALPI) Nate Lighthizer, O.D., F.A.A.O. • Argon Laser Trabeculoplasty (ALT) • Selective Laser Trabeculoplasty (SLT) • Other Laser Trabeculoplasty Why do we use lasers? Posterior Capsular Opacification (PCO) • Vision is decreased from PCO following cataract surgery • Lens capsular bag has an anterior and • Narrow angles/angle closure posterior surface • Glaucoma is progressing in a pt on max meds – Anterior surface usually removed w/ capsulorhexis – Something else needs to be done – Surgery not wanted yet • PCO is the formation of a cloudy membrane • Compliance issues on the posterior surface of the capsular bag • Cost issues following ECCE • Convenience issues – AKA: Secondary cataract • Doctor preference PCO YAG Laser • Incidence: • Nd: YAG laser – Most common complication of post ECCE – Neodymium: Yttrium aluminum garnet laser – 10-80% of eyes following cataract surgery – Can form anywhere from a few days to years post surgery • Tissue interaction: Photodisruptive laser – Younger patients higher risk of PCO – High light energy levels cause the tissues to be reduced – IOL’s to plasma, disintegrating the tissue • Silicone > acrylic – A large amount of energy is delivered into very small focal spots in a very brief duration of time • Prevention: • 4 nsec – – Capsulotomy during surgery No thermal reaction/No coagulation when bv’s are hit – Posterior capsular polishing – Pigment independent* 1 5/9/17 YAG Cap Risks, Complications, YAG Cap Pre-op Exam Contraindications • Visual acuity, glare testing, PAM/Heine lambda Contraindications Risks/complications – Vision 20/30 or worse 1.
    [Show full text]
  • Laser Procedures for the Management of Glaucoma and More Handout
    4/25/17 Overview Laser Procedures for the Management • Why we use lasers of Glaucoma and More • YAG capsulotomy Nate Lighthizer, O.D., F.A.A.O. • Laser Peripheral Iridotomy (LPI or PI) Assistant Professor, NSUOCO • Argon Laser Peripheral Iridoplasty (ALPI) Assistant Dean, Clinical Care Services • Argon Laser Trabeculoplasty (ALT) Director of CE Chief of Specialty Care Clinics • Selective Laser Trabeculoplasty (SLT) Chief of Electrodiagnostics Clinic • Other Laser Trabeculoplasty [email protected] Why do we use lasers? Posterior Capsular Opacification (PCO) • Vision is decreased from PCO following cataract surgery • Lens capsular bag has an anterior and • Narrow angles/angle closure posterior surface • Glaucoma is progressing in a pt on max meds – Anterior surface usually removed w/ capsulorhexis – Something else needs to be done – Surgery not wanted yet • PCO is the formation of a cloudy membrane • Compliance issues on the posterior surface of the capsular bag • Cost issues following ECCE • Convenience issues – AKA: Secondary cataract • Doctor preference PCO YAG Laser • Incidence: • Nd: YAG laser – Most common complication of post ECCE – Neodymium: Yttrium aluminum garnet laser – 10-80% of eyes following cataract surgery – Can form anywhere from a few days to years post surgery • Tissue interaction: Photodisruptive laser – Younger patients higher risk of PCO – High light energy levels cause the tissues to be reduced – IOL’s to plasma, disintegrating the tissue • Silicone > acrylic – A large amount of energy is delivered into very small focal spots in a very brief duration of time • Prevention: • 4 nsec – – Capsulotomy during surgery No thermal reaction/No coagulation when bv’s are hit – Posterior capsular polishing – Pigment independent* 1 4/25/17 YAG Cap Risks, Complications, YAG Cap Pre-op Exam Contraindications • Visual acuity, glare testing, PAM/Heine lambda Contraindications Risks/complications – Vision 20/30 or worse 1.
    [Show full text]
  • A Review of Selective Laser Trabeculoplasty: Recent Findings and Current Perspectives
    Ophthalmol Ther DOI 10.1007/s40123-017-0082-x REVIEW A Review of Selective Laser Trabeculoplasty: Recent Findings and Current Perspectives Yujia Zhou . Ahmad A. Aref Received: January 17, 2017 Ó The Author(s) 2017. This article is published with open access at Springerlink.com ABSTRACT explored, revealing that minor modifications may lead to a more favorable or safer clinical Selective laser trabeculoplasty (SLT) has been outcome. The utilization of postoperative widely used in the clinical management of medications remains controversial based on the glaucoma, both as primary and adjunctive current evidence. A short-term IOP increase treatment. As new evidence continues to arise, may complicate SLT and can also persist in we review the current literature in terms of certain cases such as in exfoliation glaucoma. indications and efficacy, surgical technique, The efficacy and safety of repeat SLT are shown postoperative care, repeatability, and compli- in multiple studies, and the timing of repeat cations of this therapy. SLT has been shown to procedures may affect the success rate. be effective in various glaucomas, including primary open-angle glaucoma (POAG), nor- mal-tension glaucoma (NTG), steroid-induced Keywords: Glaucoma; Intraocular pressure; glaucoma, pseudoexfoliation glaucoma (PXFG), Laser; Selective laser trabeculoplasty and primary angle-closure glaucoma (PACG), as well as other glaucoma subtypes. Relatively high preoperative intraocular pressure (IOP) INTRODUCTION may predict surgical success, while other parameters that have been studied do not seem Intraocular pressure (IOP) reduction is the to affect the outcome. Different techniques for mainstay of therapy for glaucomatous optic performing the procedure have recently been neuropathy. Selective laser trabeculoplasty (SLT) has been widely employed for this pur- Enhanced content To view enhanced content for this pose over the past several years as both a pri- article go to http://www.medengine.com/Redeem/ mary and adjunctive treatment [1].
    [Show full text]
  • Laser Trabeculoplasty for Open-Angle Glaucoma a Report by the American Academy of Ophthalmology
    Laser Trabeculoplasty for Open-Angle Glaucoma A Report by the American Academy of Ophthalmology John R. Samples, MD,1 Kuldev Singh, MD, MPH,2 Shan C. Lin, MD,3 Brian A. Francis, MD,4 Elizabeth Hodapp, MD,5 Henry D. Jampel, MD, MHS,6 Scott D. Smith, MD, MPH7 Objective: To provide an evidence-based summary of the outcomes, repeatability, and safety of laser trabeculoplasty for open-angle glaucoma. Methods: A search of the peer-reviewed literature in the PubMed and the Cochrane Library databases was conducted in June 2008 and was last repeated in March 2010 with no date or language restrictions. The search yielded 637 unique citations, of which 145 were considered to be of possible clinical relevance for further review and were included in the evidence analysis. Results: Level I evidence indicates an acceptable long-term efficacy of initial argon laser trabeculoplasty for open-angle glaucoma compared with initial medical treatment. Among the remaining studies, level II evidence supports the efficacy of selective laser trabeculoplasty for lowering intraocular pressure for patients with open-angle glaucoma. Level III evidence supports the efficacy of repeat use of laser trabeculoplasty. Conclusions: Laser trabeculoplasty is successful in lowering intraocular pressure for patients with open- angle glaucoma. At this time, there is no literature establishing the superiority of any particular form of laser trabeculoplasty. The theories of action of laser trabeculoplasty are not elucidated fully. Further research into the differences among the lasers used in trabeculoplasty, the repeatability of the procedure, and techniques of treatment is necessary. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.
    [Show full text]
  • Objective Assessment of Retinal Ganglion Cell Function in Glaucoma
    Objective Assessment of Retinal Ganglion Cell Function in Glaucoma Submitted by Nabin R. Joshi DISSERTATION In partial satisfaction of the requirements for the degree of Doctor of Philosophy SUNY College of Optometry (September 25th, 2017) 1 Abstract Background Glaucoma refers to a group of diseases causing progressive degeneration of the retinal ganglion cells. It is a clinical diagnosis based on the evidence of structural damage of the optic nerve head with corresponding visual field loss. Structural damage is assessed by visualization of the optic nerve head (ONH) through various imaging and observational techniques, while the behavioral loss of sensitivity is assessed with an automated perimeter. However, given the subjective nature of visual field assessment in patients, visual function examination suffers from high variability as well as patient and operator- related biases. To overcome these drawbacks, past research has focused on the use of objective methods of quantifying retinal function in patients with glaucoma such as electroretinograms, visually evoked potentials, pupillometry etc. Electroretinograms are objective, non-invasive method of assessing retinal function, and careful manipulation of the visual input or stimulus can result in extraction of signals particular to select classes of the retinal cells, and photopic negative response (PhNR) is a component of ERG that reflects primarily the retinal ganglion cell function. On the other hand, pupillary response to light, measured objectively with a pupillometer, also indicates the functional state of the retina and the pupillary pathway. Hence, the study of both ERGs and pupillary response to light provide an objective avenue of research towards understanding the mechanisms of neurodegeneration in glaucoma, possibly affecting the clinical care of the patients in the long run.
    [Show full text]
  • Glaucoma Comanagement: Surgical
    6/27/2017 Virginia Eye Consultants Tertiary Referral Eye Care Since 1963 • John D. Sheppard, MD, MMSc • Walter O. Whitley, OD, MBA, FAAO Innovations in Glaucoma • Stephen V. Scoper, MD • Mark Enochs, OD • David Salib, MD • Cecelia Koetting, OD, FAAO COPE#52116-GL • Elizabeth Yeu, MD • Christopher Kuc, OD • Thomas J. Joly, MD, PhD • Leanna Olennikov, OD • Dayna M. Lago, MD • Jillian Janes, OD • Constance Okeke, MD, MSCE Walter O. Whitley, OD, MBA, FAAO • Esther Chang, MD Director of Optometric Services • Jay Starling, MD Virginia Eye Consultants • Samantha Dewundara, MD Residency Program Supervisor • Surajit Saha, MD Pennsylvania College of Optometry Disclosures Walter O. Whitley, OD, MBA, FAAO has received consulting fees, honorarium or research funding from: • Alcon • Diopsys • Allergan • Ocusoft • Bausch and Lomb • Science Based Health • Biotissue • Shire • Beaver-Visitec • TearLab Corporation • Publications – Advanced Ocular Care – Co-Chief Medical Editor – Review of Optometry – Contributing Editor – Optometry Times – Editorial Advisory Board The Most Valuable Glaucoma Tool Glaucoma: Diagnosis • We know it when we see it IOP: 26 OU 1 6/27/2017 Glaucoma Diagnosis Glaucoma Diagnosis • Gonioscopy • Central corneal thickness • Visual fields • Fundus photography • Scanning lasers • Serial tonometry • Electrodiagnositics – VEP / PERG GLAUCOMA SEVERITY SCALE Managing Glaucoma Patients DEFINITIONS • Mild Stage: optic nerve changes consistent with glaucoma but • Monitor IOP reduction: 1-2 week, 1 month NO visual field abnormalities on any visual field test OR abnormalities present only on short-wavelength automated • Check IOP every 3-4 months perimetry or frequency doubling perimetry. • Repeat VF every 6-12 months • Moderate Stage: optic nerve changes consistent with • Disc photos every 1-2 years glaucoma AND glaucomatous visual field abnormalities in one hemifield and not within 5 degrees of fixation.
    [Show full text]
  • Refractive Management/Intervention 2017-2019
    Academy MOC Essentials® Practicing Ophthalmologists Curriculum 2017–2019 Refractive Management/Intervention *** Refractive Management/Intervention 2 © AAO 2017-2019 Practicing Ophthalmologists Curriculum Disclaimer and Limitation of Liability As a service to its members and American Board of Ophthalmology (ABO) diplomates, the American Academy of Ophthalmology has developed the Practicing Ophthalmologists Curriculum (POC) as a tool for members to prepare for the Maintenance of Certification (MOC) -related examinations. The Academy provides this material for educational purposes only. The POC should not be deemed inclusive of all proper methods of care or exclusive of other methods of care reasonably directed at obtaining the best results. The physician must make the ultimate judgment about the propriety of the care of a particular patient in light of all the circumstances presented by that patient. The Academy specifically disclaims any and all liability for injury or other damages of any kind, from negligence or otherwise, for any and all claims that may arise out of the use of any information contained herein. References to certain drugs, instruments, and other products in the POC are made for illustrative purposes only and are not intended to constitute an endorsement of such. Such material may include information on applications that are not considered community standard, that reflect indications not included in approved FDA labeling, or that are approved for use only in restricted research settings. The FDA has stated that it is the responsibility of the physician to determine the FDA status of each drug or device he or she wishes to use, and to use them with appropriate patient consent in compliance with applicable law.
    [Show full text]
  • Selective Laser Trabeculoplasty (SLT): 1-Year Results in Early and Advanced Open Angle Glaucoma
    Int Ophthalmol (2016) 36:55–61 DOI 10.1007/s10792-015-0079-1 ORIGINAL PAPER Selective laser trabeculoplasty (SLT): 1-year results in early and advanced open angle glaucoma Torsten Schlote . Myron Kynigopoulos Received: 7 September 2014 / Accepted: 27 April 2015 / Published online: 6 May 2015 Ó Springer Science+Business Media Dordrecht 2015 Abstract The purpose of this study was to examine (59.09 % of 44 eyes) and IOP reduction\18 mmHg/[ the efficacy of selective laser trabeculoplasty (SLT) in 30 % of the baseline IOP in 22 eyes (50 % of 44 eyes). eyes with early and more advanced stages of open SLT was safe and effective in nearly 2/3 of early angle glaucoma within 1 year of follow-up. Retro- glaucoma patients and also in 50 % of advanced spective chart review in a consecutive series of patients glaucoma patients using stronger criteria of success. treated by SLT to reduce intraocular pressure (IOP) or Failure of SLT in advanced glaucoma should lead to decrease number of topical medications in cases of immediate filtrating surgery, which seems not to be discomfort and allergy. The cup-to-disc ratio of the associated with higher risk of fibrosis. optic nerve and the GSS 2 (glaucoma staging system 2) was used to differentiate between early (group 1) and Keywords Selective laser trabeculoplasty Á more advanced (group 2) stages of glaucoma. At the Trabeculoplasty Á Glaucoma Á Intraocular pressure time of SLT treatment, no new signs of glaucoma progression were seen. Only the first treated eye of every patient was included in the analysis. In group 1 Introduction (early glaucoma), 27 eyes were included.
    [Show full text]
  • Gonioscopy—A Primer
    Review Glaucoma Gonioscopy—A Primer Syed Shoeb Ahmad Queen Elizabeth Hospital, Kota Kinabalu, Malaysia DOI: https://doi.org/10.17925/USOR.2017.10.01.42 ssessment of the anterior chamber angle (ACA) is an indispensible investigation for evaluation of glaucoma. The most commonly performed method for the determination of the ACA is gonioscopy. This technique, while being simple, is often hampered by the A subjective nature of the procedure, especially in inexperienced hands. This review is intended to improve the knowledge, attitude, and practice among the practitioners regarding the procedure of gonioscopy. Keywords Gonioscopy is a requisite investigation for all patients with glaucoma. It is a procedure for evaluation Gonioscopy, anterior chamber, glaucoma of the anterior chamber angle (ACA), utilizing special instruments known as gonio-lenses or -prisms. angle-closure, glaucoma open-angle Alexios Trantas (1867–1961) was the first to use the term “gonioscopy” in 1907 (Figure 1). The term was derived from the Greek word “gonia” meaning angle and “skopein” to observe. Trantas used a direct Disclosure: Syed Shoeb Ahmad has nothing to disclose in relation to this article. This study involves a review of ophthalmoscope and digital pressure at the limbus to observe the ACA in a patient with keratoglobus. the literature and did not involve any studies with human Later, Maxmilian Salzmann (1862–1954) used indirect gonioscopy with a contact lens for examination or animal subjects performed by any of the authors. No funding was received for the publication of this article. of the angle (Figure 1).1 Therefore, both Trantas and Salzmann are called the “Fathers of gonioscopy”.1,2 Acknowledgements: Syed Shoeb Ahmad wishes to thank the Secretariat of the Greek Glaucoma Society, Dr Gonioscopy helps to categorize the type of glaucoma, that is, open- or closed-angle.
    [Show full text]
  • Selective Laser Trabeculoplasty: an Update
    REVIEW ARTICLE Selective Laser Trabeculoplasty: An Update Jeffrey B. Kennedy, MD, Jeffrey R. SooHoo, MD, Malik Y. Kahook, MD, and Leonard K. Seibold, MD Abstract: without causing significant collateral thermal damage. This pro- Selective laser trabeculoplasty (SLT) is an effective treatment cedure is typically performed using a nonmagnified, mirrored option for the reduction of intraocular pressure (IOP) in patients with ocu- goniolens such as the Latina SLT lens (Ocular Instruments, Bellevue, lar hypertension or open-angle glaucoma. The mechanism by which SLT Wash) and a methycellulose or artificial tear gel coupling solu- lowers IOP is not completely understood and is likely multifactorial. Pub- tion. The SLT laser is a 532-nm frequency-doubled Q-switched lished studies indicate that SLT is at least as effective as argon laser Nd:YAG laser, with a fixed spot size of 400 μmanddurationof trabeculoplasty or medications at lowering IOP in many forms of glau- 3 nanoseconds. The power range for treatment using currently coma. In addition to IOP reduction, SLT may decrease IOP fluctuation available laser platforms is 0.3 to 2.0 mJ, with typical treatments and can be successfully used as primary or adjunctive therapy for the man- ranging from 0.4 to 1.4 mJ. These parameters spare surrounding agement of both early and advanced glaucoma. However, SLT may not be nonpigmented cells because the pulse duration is sufficiently effective in certain forms of glaucoma, and the IOP-lowering effect seems shorter than the thermal relaxation time (1 μs) of melanin granules to wane with time. High pretreatment IOP is the strongest predictor of treat- contained in pigmented TM cells.10 ment success, even in patients with normal-tension glaucoma.
    [Show full text]
  • Laser Therapy for the Open Angle Glaucomas
    LASER THERAPY FOR THE OPEN ANGLE GLAUCOMAS Cliff M. Caudill, O.D., FAAO OPEN ANGLE GLAUCOMA • Primary Open Angle, aka Chronic Open Angle • POAG/COAG • Secondary Open Angle Glaucoma • Pigmentary Glaucoma • Exfoliative Glaucoma • Traumatic • Uveitic • Congential • Neovascular OBJECTIVE VISUAL FIELD???? • This just in….OBJECTIVE visual field testing • Konan Engineering • https://konanmedical.com/objectivefield/ • Uses pupil response to stimuli to assess retinal function • Kinda like mfERG but uses pupil response instead of electrical response TRADITIONAL GLAUCOMA FLOWCHART Meds LTP Surgery PARADIGM SHIFTING LTP Meds Surgery TYPICAL BEST CANDIDATES FOR LTP • POAG, of course • Ocular Hypertensives • Pigmentary Dispersion syndrome (maybe LPI too…talk about that later) • Non-compliant patients • Sometimes not by choice • Patients unable to afford meds LASER THERAPY IN GLAUCOMA GONIOSCOPY REVIEW GONIOSCOPY GONIOSCOPY REVIEW GONAK IS BACK! • Contact/Interface Solutions • Goniosol: Hydroxypropyl Methylcellulose 2.5% • traditional solution of choice for 3 mirror gonioscopy • Advantage: clear view, less bubbles • Disadvantage: allergic/toxicity reactions to high % of methylcellulose results in disruption of corneal epithelium, reduced VA, discomfort; requires rinsing GONIOSCOPY REVIEW • Contact Solutions, continued • Celluvisc (Carboxymethylcellulose Sodium 1%) • Advantages: readily available, disposable single use vials, easier on corneas, does not require rinsing • Disadvantages: doesn’t “stick” as well, more prone to bubbles • Genteal Gel: equivalent
    [Show full text]